Attorney Profile

Michael E. Clark

Michael Clark

Duane Morris LLP
1330 Post Oak Boulevard, Suite 800
Houston, TX 77056-3166

Houston

Texas (TX)

Contact Contact Michael E. Clark
T: 713-402-3905
F: 713-583-9182

Visit: www.duanemorris.com
Practice Areas: Health Care (40%), Criminal Defense: White Collar (30%), Business Litigation (30%)

Health Care

Criminal Defense: White Collar

Business Litigation

Industry Groups: Life Sciences; Pharmaceutical; Securities

Profile

I'm assigned to Duane Morris' Trial Practice and Health Care Practice Groups. I've served as lead counsel in over 100 jury trials, handled dozens of appeals and for years have taught trial and deposition skills to lawyers and law students though the National Institute on Trial Advocacy and the Trial Advocacy Program at the University of Houston Law Center. Before entering private practice I served as a federal and state prosecutor, and was the Chief of the Criminal Division for the U.S. Attorney's Office in the Southern District of Texas, where I tried several high profile fraud prosecutions.

I represent clients in complex and high-stakes civil and white collar litigation. I also conduct internal investigations, assist clients with crisis management, and provide counsel for fraud and abuse and corporate governance matters. I have experience in a variety of areas, including securities and financial fraud and life sciences.

I've been interviewed by many media sources, including the AP; Bloomberg Business, CBC, CNBC; CNN; Crain Chicago; Dallas Morning News; 48 Hours; Fox Financial, Health Channel; Health News Florida; Houston Chronicle; National Law Journal; New York Law Journal; New York Times; Reuters/Thomson, Texas Lawyer; Washington Post; Wolters Kluwer; and USA Today.

I'm an Adjunct Professor of Law, a NITA faculty instructor, extensively published and frequently present to professional groups. In addition to my JD, I have LLMs in Taxation and Health Law. I'm also a trained Health Law Arbitrator (by AHLA).

Within the American Bar Association, I'm the Chair-Elect of the Section of Health Law. I co-chair and serve on the Planning Committee for the ABA's National Institute on Internal Investigations and Forum for In-House Counsel and the National False Claim Act Trial Institute. I've served on the ABA-wide Standing Committee on Publishing Oversight and am a past Chair of the Business Law Section’s White-Collar Crime Committee (and a past editorial board member of The Business Lawyer). I've also served on the Planning Committee for the ABA's National Institute on Securities Fraud. I'm also a Fellow of the American Bar Foundation and a member of DRI.

I developed and am Editor-in-Chief of an annually supplemented pharmaceutical law treatise published by BNA in 2007 and have authored chapters in other pubished books and dozens of published articles. I'm currently working on a Money Laundering Treatise for American Lawyer Media.

Since the late 1980's, I have been Board Certified in Criminal Law by both the Texas Board of Legal Specialization and the National Board of Trial Advocacy.


Years of Selection

• Super Lawyers: 2007 - 2013

Certifications and Credentials

International Locations

Countries: Mexico, Singapore, United Kingdom, Vietnam


About Michael Clark

Admitted: 1982, Texas

Professional Webpage: www.duanemorris.com/attorneys/michaeleclark.html

Honors and Awards:

Special Licenses/Certifications:

  • Board Certified, Criminal Trial Advocate, National Board of Trial Advocacy, 1989
  • Board Certified, Criminal Law Specialist, Texas Board of Legal Specialization, 1988

Bar/Professional Activity:

  • Co-chair, Internal Investigations Subcommittee, Corporate Compliance Committee, ABA Section of Business Law, 2009
  • Financial Subcommittee Chair, Government Enforcement and Corporate Compliance Committee; Public Relations Contact, DRI, 2008
  • Co-chair, South Texas Region, White Collar Crimes Committee, ABA Criminal Justice Section, 2007
  • Member, Standing Committee on Publishing Oversight, American Bar Association, 2007
  • Governing Council, ABA Health Law Section, 2007
  • Chair, White Collar Crimes Committee, ABA Section of Business Law, 2005
  • Chair, Executive Publications Committee, ABA Health Law Section, 2005
  • Advisory Board, University of Houston Law Center, Criminal Justice Institute, 2005

Pro bono/Community Service:

  • Secretary and Treasurer, Foundation for Cancer Survivors (Cancer Forward), 2013
  • National Institute for Trial Advocacy's (NITA) Deposition Skills Program, Houston, TX, 2013, 2013
  • Faculty, National Institute for Trial Advocacy's (NITA) Deposition Skills Program, Houston, TX, 2012
  • Adjunct Faculty, University of Houston Law Center, Intersession Course: Taking and Defending Depositions, 2008

Scholarly Lectures and Writings:

Other Outstanding Achievements:

  • Adjunct Professor, University of Florida, College of Pharmacy (Pharmaceutical Fraud and Abuse), 2013
  • Faculty, NITA Advanced Deposition Institute, 2010
  • Adjunct Professor, Food and Drug Law; Antitrust & Health Law, Health Law & Policy Institute, University of Houston Law Center; Adjunct Professor, Civil Trial Advocacy; Criminal Trial Advocacy, University of Houston Law Center; Faculty, NITA Southern Regional Program (SMU); Faculty, NITA Deposition Program (University of Houston Law Center)

Newsletters:

Educational Background:

  • LL.M. (Health Law) University of Houston Law Center, 2000
  • LL.M. (Taxation) University of Houston Law Center, 1996
  • JD (South Texas College of Law), 1982
  • BA (English) (University of Texas, Arlington), 1979

Map Location

Blog entries — Michael E. Clark

White Papers

The Responsible Corporate Officer Doctrine (The Crime of Doing Nothing) - (2011)

This paper submitted for a presentation in October 2011 at the New York State Bar Association's Fourth Corporate Counsel Institute addresses how the Responsible Corporate Officer Doctrine is being used by various agencies in administrative, civil, and criminal cases, along with some recent and provocative examples of how it has been wielded against executives in the Health Law area

Whistleblower Risks Just Increased: What to Watch Out For - (2010)

This advertorial in Modern Healthcare provides a summary of the new and expanded whistleblower provisions authorized by Congress in the Dodd-Frank Act related to SEC and CFTC whistleblowers, the bounties they may receive for providing original information about securities and commodities violations, and the likely impact this will have on companies' ongoing compliance activities as well as additional litigation, civil and criminal.

Industry Group(s): Life Sciences

New Whistleblower Incentives and Protections, and More Enforcement Expected. - (2010)

This firm alert addresses the new and expanded SEC and CFTC whistleblower provisions, and related measures, authorized by Congress in the Dodd-Frank Act, along with some open issues and likely consequences from these new measures


Super Lawyers Magazine
What is Super Lawyers

Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement. The selection process includes independent research, peer nominations and peer evaluations.

Read more »

 

Find Us On

International

Super Lawyers UK Super Lawyers US